CFZ533, a New Anti-CD40 mAB Demonstrates Comparable Efficacy and Better Renal Function versus Tacrolimus in De-Novo CNI-Free Kidney Transplantation.
- Resource Type
- Journal
- Authors
- Nashan, B.; Tedesco, H.; van den Hoogen, M.; Berger, S.; Cibrik, D.; Mulgaonkar, S.; Leeser, D.; Alloway, R.; Patel, A.; Pratschke, J.; Sommerer, C.; Wiseman, A.; van Zuilen, A.; Laessing, U.; Rush, J.; Haraldsson, B.; Witzke, O.
- Source
- AMERICAN JOURNAL OF TRANSPLANTATION; JUN 2018, 18 p400-p400, 1p. Supplement: 4
- Subject
- Language
- English
- ISSN
- 16006143